Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526643
Status:
TERMINATED
Last Update Posted:
2017-03-28
First Post:
2007-09-06
Brief Title:
CAPPA-2 Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
Sponsor:
National Cancer Institute Naples
Organization:
National Cancer Institute Naples